Morgan Stanley
GTBP icon

Morgan Stanley’s GT Biopharma GTBP Stock Holding History

Morgan Stanley’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.1K Buy
903
+239
+36% +$2.42K ﹤0.01% 7016
2026
Q1 		$6.77K Sell
664
-80
-11% -$1.09K ﹤0.01% 7063
2025
Q4 		$14.6K Buy
744
+183
+33% +$3.25K ﹤0.01% 6795
2025
Q3 		$8.22K Buy
561
+400
+248% +$14.9K ﹤0.01% 6955
2025
Q2 		$14.4K Buy
161
+20
+14% +$1.29K ﹤0.01% 6757
2025
Q1 		$7.6K Hold
141
– – ﹤0.01% 6884
2024
Q4 		$10.8K Buy
141
+130
+1,182% +$8.79K ﹤0.01% 6777
2024
Q3 		$614 Hold
11
– – ﹤0.01% 7278
2024
Q2 		$753 Hold
11
– – ﹤0.01% 7188
2024
Q1 		$1.18K Hold
11
– – ﹤0.01% 7151
2023
Q4 		$2.06K Hold
11
– – ﹤0.01% 7035
2023
Q3 		$1.95K Hold
11
– – ﹤0.01% 7137
2023
Q2 		$2.52K Hold
11
– – ﹤0.01% 7142
2023
Q1 		$4.44K Buy
11
+1
+10% +$573 ﹤0.01% 7080
2022
Q4 		$6.92K Buy
10
+5
+100% +$6.24K ﹤0.01% 7060
2022
Q3 		$5K Sell
5
-174
-97% -$333K ﹤0.01% 7251
2022
Q2 		$400K Sell
179
-177
-50% -$335K ﹤0.01% 5530
2022
Q1 		$768K Sell
356
-234
-40% -$516K ﹤0.01% 5151
2021
Q4 		$1.35M Buy
590
+254
+76% +$950K ﹤0.01% 4866
2021
Q3 		$1.7M Buy
336
+290
+630% +$2.18M ﹤0.01% 4698
2021
Q2 		$540K Buy
46
+43
+1,433% +$447K ﹤0.01% 5476
2021
Q1 		$18K Buy
+3
New +$13.1K ﹤0.01% 6755

Other funds holding GTBP

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
EFG
Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return
AAP
Arax Advisory Partners Denver, Colorado $15.1B AUM 27.93% 1-Year Est. Return
OWA
Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $524M AUM 16.59% 1-Year Est. Return
A
Alongside Austin, Texas $525M AUM

Morgan Stanley's GTBP Position: Q2 2026 in Review

Morgan Stanley increased its GT Biopharma (GTBP) stake by 36% in Q2 2026, buying an estimated $2.42K and bringing the position to 903 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #7016.

Morgan Stanley first reported a position in GTBP in Q1 2021 and has held it in 22 quarters since. The position peaked at $1.7M in Q3 2021. 55 funds tracked by Wall St. Rank hold GTBP as of Q2 2026.

  • Morgan Stanley held 903 shares of GT Biopharma worth $11.1K as of Q2 2026.
  • Morgan Stanley bought 239 GT Biopharma shares in Q2 2026, an estimated $2.42K.
  • GT Biopharma made up ﹤0.01% of Morgan Stanley's portfolio in Q2 2026, its #7016 holding.
  • Morgan Stanley first reported a position in GT Biopharma in Q1 2021 and has held it in 22 quarters since.
  • Morgan Stanley's GT Biopharma position peaked at $1.7M in Q3 2021.
  • 55 funds tracked by Wall St. Rank held GT Biopharma as of Q2 2026.

Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.